肺がん手術リスクを予測するAIツール開発 (AI Tool Assesses Lung Cancer Surgery Risk)

ad

2026-04-24 バッファロー大学(UB)

米国のUniversity at BuffaloとRoswell Park Comprehensive Cancer Centerの研究チームは、肺がんリスクを評価するAIツールを開発した。CT画像などの医療データを解析し、患者ごとの発症リスクを高精度に予測することが可能で、早期発見やスクリーニングの効率化に寄与する。従来の臨床判断に比べ、より客観的かつ個別化された評価を提供できる点が特徴であり、不要な検査の削減や医療資源の最適配分にもつながると期待される。今後は臨床現場での検証を進め、実用化を目指す。本研究はAIと医療の融合による精密医療の進展を示す重要な成果である。

肺がん手術リスクを予測するAIツール開発 (AI Tool Assesses Lung Cancer Surgery Risk)

<関連情報>

肺がん手術における術後合併症予測のためのLLM拡張型介入可能マルチモーダルアダプター LLM Augmented Intervenable Multimodal Adaptor for Post-operative Complication Prediction in Lung Cancer Surgery

Shubham Pandey, Bhavin Jawade, Srirangaraj Setlur, Venu Govindaraju, Kenneth Seastedt
arXiv  Submitted on 20 Jan 2026
DOI:https://doi.org/10.48550/arXiv.2601.14154

Abstract

Postoperative complications remain a critical concern in clinical practice, adversely affecting patient outcomes and contributing to rising healthcare costs. We present MIRACLE, a deep learning architecture for prediction of risk of postoperative complications in lung cancer surgery by integrating preoperative clinical and radiological data. MIRACLE employs a hyperspherical embedding space fusion of heterogeneous inputs, enabling the extraction of robust, discriminative features from both structured clinical records and high-dimensional radiological images. To enhance transparency of prediction and clinical utility, we incorporate an interventional deep learning module in MIRACLE, that not only refines predictions but also provides interpretable and actionable insights, allowing domain experts to interactively adjust recommendations based on clinical expertise. We validate our approach on POC-L, a real-world dataset comprising 3,094 lung cancer patients who underwent surgery at Roswell Park Comprehensive Cancer Center. Our results demonstrate that MIRACLE outperforms various traditional machine learning models and contemporary large language models (LLM) variants alone, for personalized and explainable postoperative risk management.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました